DE3483055D1 - Grenzflaechenaktives mittel und dieses enthaltende arzneimittel zur verwendung bei der behandlung des atemnotsyndroms. - Google Patents
Grenzflaechenaktives mittel und dieses enthaltende arzneimittel zur verwendung bei der behandlung des atemnotsyndroms.Info
- Publication number
- DE3483055D1 DE3483055D1 DE8484301513T DE3483055T DE3483055D1 DE 3483055 D1 DE3483055 D1 DE 3483055D1 DE 8484301513 T DE8484301513 T DE 8484301513T DE 3483055 T DE3483055 T DE 3483055T DE 3483055 D1 DE3483055 D1 DE 3483055D1
- Authority
- DE
- Germany
- Prior art keywords
- treating
- active agent
- product containing
- surfactant
- respiratory syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0082—Lung surfactant, artificial mucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58038189A JPS59164724A (ja) | 1983-03-10 | 1983-03-10 | サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3483055D1 true DE3483055D1 (de) | 1990-10-04 |
Family
ID=12518415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8484301513T Revoked DE3483055D1 (de) | 1983-03-10 | 1984-03-07 | Grenzflaechenaktives mittel und dieses enthaltende arzneimittel zur verwendung bei der behandlung des atemnotsyndroms. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4603124A (de) |
EP (1) | EP0119056B1 (de) |
JP (1) | JPS59164724A (de) |
AT (1) | ATE55908T1 (de) |
AU (1) | AU562676B2 (de) |
CA (1) | CA1208129A (de) |
DE (1) | DE3483055D1 (de) |
GR (1) | GR81930B (de) |
IE (1) | IE57006B1 (de) |
MX (1) | MX9203493A (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5430020A (en) * | 1984-12-11 | 1995-07-04 | Scios Nova Inc. | Recombinant alveolar surfactant protein |
US5110806A (en) * | 1985-06-26 | 1992-05-05 | The Regents Of The University Of California | Lung surfactant compositions |
DE3528934A1 (de) * | 1985-08-13 | 1987-02-26 | Feldmuehle Ag | Gleitelement aus keramischem werkstoff |
WO1987002037A1 (en) * | 1985-09-26 | 1987-04-09 | Genetics Institute, Inc. | Pulmonary surfactant proteins |
US5256569A (en) * | 1986-01-21 | 1993-10-26 | Chisso Corporation | Transesterification process for otereoselection of enantiomers of secondary alcohols using pseudomonas lipase with no added solvent |
IT1203873B (it) * | 1987-04-08 | 1989-02-23 | Chiesi Farma Spa | Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e |
US4861756A (en) * | 1988-03-08 | 1989-08-29 | Merrell Dow Pharmaceuticals Inc. | Synthetic pulmonary surfactant |
DE3921954A1 (de) * | 1989-07-04 | 1991-01-17 | Thomae Gmbh Dr K | Niedrig-viskose, hochkonzentrierte surfactant-suspension |
US5174988A (en) * | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
US5207220A (en) * | 1989-12-12 | 1993-05-04 | Burroughs Wellcome Co. | Method for administering pharmaceuticals, including liquid surfactant, to the lungs |
FR2658418B1 (fr) * | 1990-02-20 | 1994-09-02 | Synthelabo | Compositions pharmaceutiques a base de phospholipides. |
DE69131163T2 (de) * | 1990-05-18 | 1999-12-23 | Tokyo Tanabe Co | Asthma heilmittel |
US5614216A (en) * | 1990-10-17 | 1997-03-25 | The Liposome Company, Inc. | Synthetic lung surfactant |
JP3961029B2 (ja) * | 1992-06-24 | 2007-08-15 | 博 木戸 | インフルエンザウィルス感染防止剤 |
DE4418936A1 (de) * | 1994-05-31 | 1996-02-08 | Byk Gulden Lomberg Chem Fab | Polypeptid |
BR9506114A (pt) * | 1994-12-29 | 1997-12-23 | Ctro Nac Sanidad Agropecuaria | Tensoativo pulmonar de origem suína e processo para a sua obtenção |
US6129934A (en) * | 1995-06-07 | 2000-10-10 | Ony, Inc. | Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction |
US6315983B1 (en) | 1996-01-24 | 2001-11-13 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Process for the production of powdered pulmonary surfactant preparations |
US6172203B1 (en) * | 1996-02-07 | 2001-01-09 | Alfredo Adolfo Hager | Method for extracting and purifying pulmonary surfactant |
WO1997035882A1 (en) * | 1996-03-27 | 1997-10-02 | Ortho Pharmaceutical Corporation | Lyophilized pulmonary surfactant peptide compositions |
US5667948A (en) * | 1996-04-16 | 1997-09-16 | Eastman Kodak Company | Processing silver halide films with an aqueous phospholipid rinse solution |
AU1250999A (en) | 1997-12-24 | 1999-07-19 | Britannia Pharmaceuticals Limited | Use of surface active agent for the manufacture of a medicament for treatment ofdisorders of the middle ear |
EP1216052A1 (de) | 1999-09-16 | 2002-06-26 | Byk Gulden Lomberg Chemische Fabrik GmbH | Kombination eines c1-inh und eines lungensurfactant zur behandlung von respirationstörungen |
DE10018022A1 (de) * | 2000-04-12 | 2001-10-31 | Byk Gulden Lomberg Chem Fab | Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen |
GB0026239D0 (en) * | 2000-10-26 | 2000-12-13 | Britannia Pharmaceuticals Ltd | Surface active lipids in treatment of wet lung |
AU2002338882B2 (en) | 2001-10-11 | 2008-04-03 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Novel use of pulmonary surfactant |
EP1481665A1 (de) * | 2003-05-30 | 2004-12-01 | CHIESI FARMACEUTICI S.p.A. | Neue Lipidmischungen für synthetische Tenside |
WO2006013183A1 (en) | 2004-08-06 | 2006-02-09 | Altana Pharma Ag | Composition comprising a pulmonary surfactant and a tnf-derived peptide |
US7582312B2 (en) * | 2004-11-15 | 2009-09-01 | Discovery Laboratories, Inc. | Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
US8337815B2 (en) * | 2004-12-23 | 2012-12-25 | Discovery Laboratories, Inc. | Pulmonary surfactant formulations |
US7951781B2 (en) | 2006-11-02 | 2011-05-31 | University Of Iowa Research Foundation | Methods and compositions related to PLUNC surfactant polypeptides |
US9289388B2 (en) | 2008-12-10 | 2016-03-22 | Paka Pulmonary Pharmaceuticals, Inc. | Methods and compositions for delivery of medicaments to the lungs |
EP2608769B1 (de) | 2010-08-23 | 2019-11-06 | Fraunhofer Gesellschaft zur Förderung der Angewand | Befeuchtete partikel mit einem wirkstoff |
HUE026363T2 (en) * | 2012-03-28 | 2016-06-28 | Discovery Lab Inc | Lyophilization of pulmonary synthetic liposomal surfactant |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE388023C (de) * | 1922-02-14 | 1924-01-07 | Chem Fab | Verfahren zur Herstellung von waesserigen Lezithinemulsionen |
FR2343481A1 (fr) * | 1976-03-11 | 1977-10-07 | Gerlich Norbert | Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees |
DE2900300A1 (de) * | 1979-01-05 | 1980-07-17 | Lebrecht Von Dr Klitzing | Verfahren einer prophylaxe zur vermeidung des atemnotsyndroms bei fruehgeborenen und bei der schocklunge |
JPS55160721A (en) * | 1979-06-02 | 1980-12-13 | Tokyo Tanabe Co Ltd | Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent |
US4312860A (en) * | 1980-10-24 | 1982-01-26 | Regents Of The University Of California | Lung surfactant compositions |
JPS5845299A (ja) * | 1981-09-10 | 1983-03-16 | 東京田辺製薬株式会社 | 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤 |
-
1983
- 1983-03-10 JP JP58038189A patent/JPS59164724A/ja active Granted
-
1984
- 1984-02-27 US US06/583,866 patent/US4603124A/en not_active Expired - Lifetime
- 1984-02-28 AU AU25125/84A patent/AU562676B2/en not_active Expired
- 1984-03-07 EP EP84301513A patent/EP0119056B1/de not_active Revoked
- 1984-03-07 AT AT84301513T patent/ATE55908T1/de not_active IP Right Cessation
- 1984-03-07 IE IE553/84A patent/IE57006B1/en not_active IP Right Cessation
- 1984-03-07 GR GR74015A patent/GR81930B/el unknown
- 1984-03-07 DE DE8484301513T patent/DE3483055D1/de not_active Revoked
- 1984-03-09 CA CA000449223A patent/CA1208129A/en not_active Expired
-
1992
- 1992-06-26 MX MX9203493A patent/MX9203493A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ATE55908T1 (de) | 1990-09-15 |
IE57006B1 (en) | 1992-03-11 |
AU562676B2 (en) | 1987-06-18 |
EP0119056A2 (de) | 1984-09-19 |
US4603124A (en) | 1986-07-29 |
JPH0378371B2 (de) | 1991-12-13 |
AU2512584A (en) | 1984-09-13 |
IE840553L (en) | 1984-09-10 |
EP0119056A3 (en) | 1986-06-25 |
EP0119056B1 (de) | 1990-08-29 |
JPS59164724A (ja) | 1984-09-17 |
CA1208129A (en) | 1986-07-22 |
GR81930B (de) | 1984-12-12 |
MX9203493A (es) | 1992-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3483055D1 (de) | Grenzflaechenaktives mittel und dieses enthaltende arzneimittel zur verwendung bei der behandlung des atemnotsyndroms. | |
ATE113834T1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
DE68904530T3 (de) | Biologisch wirksames Lipoprotein und seine Verwendung. | |
JPS5799524A (en) | Mammal lung surface active drug composition | |
ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
GR3019315T3 (en) | Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders | |
DE3855113T2 (de) | Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht | |
DE69214467D1 (de) | Verwendung von Thiazolidin-4-carboxylatderivaten zur Behandlung von Lungenerkrankungen | |
ATE35415T1 (de) | Pharmazeutische zusammensetzungen und verfahren fuer die herstellung von zusammensetzungen mit gehalt an phosphatidylserine zur behandlung von stoerungen des centralen nervensystems ohne wirkungen auf die blutkoagulation. | |
DE69122364D1 (de) | Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen | |
ATE227304T1 (de) | Tetraetherlipide und diese enthaltende liposomen sowie deren verwendung | |
ATE183651T1 (de) | Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen | |
DE69131553T2 (de) | Arzneimittel enthaltend Mischungen von höheren primären aliphatischen Alkoholen zur Behandlung von Hypercholesterolämie und Hyperlipoproteinämie Typ II und zur Stimulation des sexuellen Verhaltens bei Tieren und Menschen | |
ATE3552T1 (de) | Verfahren zur herstellung von phosphono-hydroxy- essigsaeure und salzen derselben sowie diese enthaltende autivirale mittel. | |
ES482684A1 (es) | Procedimiento de preparacion de nuevos derivados de la pipe-ridilbencimidazolinona y de sus sales de adicion con acidos apropiados. | |
DE69132211D1 (de) | Synthetische oberflächenaktive agentien auf der lunge | |
PT70288A (de) | Carbanilsaure-/3-(alkylcarbonylamino)-phenyl/-ester verfahren zur herstellung dieser verbindungen sowie diese enthaltendes herbizides mittel | |
EP0238198A3 (de) | Verfahren zur Abänderung der Lipid-Struktur-Funktion und von Zellmembranen und pharmazeutische Zusammensetzungen zur Verwendung dabei | |
JPS5626819A (en) | Preventive for hypoimmunity | |
DE69307197D1 (de) | Verwendung von 24,25-Dihydroxyvitamin-D3 zur Herstellung eines Arzneimittel zur Behandlung der Rachitis | |
NO894083D0 (no) | Framsoeytiske blandinger for behandling av adrenoleukodystrophy. | |
NO913685L (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
ATE119908T1 (de) | 2-formylbenzylphosphonsäure-derivate, deren herstellung und ihre verwendung zur behandlung von durch viren verursachte krankheiten. | |
DE69211743D1 (de) | Aureobasidin enthaltendes Arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8331 | Complete revocation |